ARCHIVES

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

February 6, 1981

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

February 8, 1991

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976